Targeted in vivo inhibition of specific protein-protein interactions using recombinant antibodies.

With the growing availability of genomic sequence information, there is an increasing need for gene function analysis. Antibody-mediated "silencing" represents an intriguing alternative for the precise inhibition of a particular function of biomolecules. Here, we describe a method for sele...

Full description

Bibliographic Details
Main Authors: Matej Zábrady, Vendula Hrdinová, Bruno Müller, Udo Conrad, Jan Hejátko, Lubomír Janda
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4192540?pdf=render
id doaj-189ad747e5b746ffa2a0f954e465b02e
record_format Article
spelling doaj-189ad747e5b746ffa2a0f954e465b02e2020-11-24T21:08:12ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01910e10987510.1371/journal.pone.0109875Targeted in vivo inhibition of specific protein-protein interactions using recombinant antibodies.Matej ZábradyVendula HrdinováBruno MüllerUdo ConradJan HejátkoLubomír JandaWith the growing availability of genomic sequence information, there is an increasing need for gene function analysis. Antibody-mediated "silencing" represents an intriguing alternative for the precise inhibition of a particular function of biomolecules. Here, we describe a method for selecting recombinant antibodies with a specific purpose in mind, which is to inhibit intrinsic protein-protein interactions in the cytosol of plant cells. Experimental procedures were designed for conveniently evaluating desired properties of recombinant antibodies in consecutive steps. Our selection method was successfully used to develop a recombinant antibody inhibiting the interaction of ARABIDOPSIS HISTIDINE PHOSPHOTRANSFER PROTEIN 3 with such of its upstream interaction partners as the receiver domain of CYTOKININ INDEPENDENT HISTIDINE KINASE 1. The specific down-regulation of the cytokinin signaling pathway in vivo demonstrates the validity of our approach. This selection method can serve as a prototype for developing unique recombinant antibodies able to interfere with virtually any biomolecule in the living cell.http://europepmc.org/articles/PMC4192540?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Matej Zábrady
Vendula Hrdinová
Bruno Müller
Udo Conrad
Jan Hejátko
Lubomír Janda
spellingShingle Matej Zábrady
Vendula Hrdinová
Bruno Müller
Udo Conrad
Jan Hejátko
Lubomír Janda
Targeted in vivo inhibition of specific protein-protein interactions using recombinant antibodies.
PLoS ONE
author_facet Matej Zábrady
Vendula Hrdinová
Bruno Müller
Udo Conrad
Jan Hejátko
Lubomír Janda
author_sort Matej Zábrady
title Targeted in vivo inhibition of specific protein-protein interactions using recombinant antibodies.
title_short Targeted in vivo inhibition of specific protein-protein interactions using recombinant antibodies.
title_full Targeted in vivo inhibition of specific protein-protein interactions using recombinant antibodies.
title_fullStr Targeted in vivo inhibition of specific protein-protein interactions using recombinant antibodies.
title_full_unstemmed Targeted in vivo inhibition of specific protein-protein interactions using recombinant antibodies.
title_sort targeted in vivo inhibition of specific protein-protein interactions using recombinant antibodies.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description With the growing availability of genomic sequence information, there is an increasing need for gene function analysis. Antibody-mediated "silencing" represents an intriguing alternative for the precise inhibition of a particular function of biomolecules. Here, we describe a method for selecting recombinant antibodies with a specific purpose in mind, which is to inhibit intrinsic protein-protein interactions in the cytosol of plant cells. Experimental procedures were designed for conveniently evaluating desired properties of recombinant antibodies in consecutive steps. Our selection method was successfully used to develop a recombinant antibody inhibiting the interaction of ARABIDOPSIS HISTIDINE PHOSPHOTRANSFER PROTEIN 3 with such of its upstream interaction partners as the receiver domain of CYTOKININ INDEPENDENT HISTIDINE KINASE 1. The specific down-regulation of the cytokinin signaling pathway in vivo demonstrates the validity of our approach. This selection method can serve as a prototype for developing unique recombinant antibodies able to interfere with virtually any biomolecule in the living cell.
url http://europepmc.org/articles/PMC4192540?pdf=render
work_keys_str_mv AT matejzabrady targetedinvivoinhibitionofspecificproteinproteininteractionsusingrecombinantantibodies
AT vendulahrdinova targetedinvivoinhibitionofspecificproteinproteininteractionsusingrecombinantantibodies
AT brunomuller targetedinvivoinhibitionofspecificproteinproteininteractionsusingrecombinantantibodies
AT udoconrad targetedinvivoinhibitionofspecificproteinproteininteractionsusingrecombinantantibodies
AT janhejatko targetedinvivoinhibitionofspecificproteinproteininteractionsusingrecombinantantibodies
AT lubomirjanda targetedinvivoinhibitionofspecificproteinproteininteractionsusingrecombinantantibodies
_version_ 1716760472348262400